Through ongoing collaboration, new companion diagnostic aims to deliver next-generation sequencing results in as little as 24 hours to help advance precision oncology.

While 90 may not be the new 40, it may become the new 75 or 80 as science, technology and policies converge to leverage the gains from the genomics revolution, which are making precision medicine a clinical reality.